Fox Run Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,901
Closed -$309K 992
2022
Q4
$309K Buy
+9,901
New +$309K 0.12% 339